The Rockefeller University Clinical Scholars (KL2) program 2006–2016

Introduction and Methods The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program....

Full description

Bibliographic Details
Main Authors: Sarah J. Schlesinger, Michelle Romanick, Jonathan N. Tobin, Donna Brassil, Rhonda G. Kost, Rita Devine, Barbara O’Sullivan, Roger D. Vaughan, Yupu Liang, Joel Correa da Rosa, Maija Williams, James G. Krueger, Barry S. Coller
Format: Article
Language:English
Published: Cambridge University Press 2017-10-01
Series:Journal of Clinical and Translational Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2059866117003089/type/journal_article
_version_ 1811156853143371776
author Sarah J. Schlesinger
Michelle Romanick
Jonathan N. Tobin
Donna Brassil
Rhonda G. Kost
Rita Devine
Barbara O’Sullivan
Roger D. Vaughan
Yupu Liang
Joel Correa da Rosa
Maija Williams
James G. Krueger
Barry S. Coller
author_facet Sarah J. Schlesinger
Michelle Romanick
Jonathan N. Tobin
Donna Brassil
Rhonda G. Kost
Rita Devine
Barbara O’Sullivan
Roger D. Vaughan
Yupu Liang
Joel Correa da Rosa
Maija Williams
James G. Krueger
Barry S. Coller
author_sort Sarah J. Schlesinger
collection DOAJ
description Introduction and Methods The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program. The program consists of ∼15 trainees supported by the Clinical and Translational Science Award KL2 award and University funds. It is designed to provide an optimal environment for junior translational investigators to develop team science and leadership skills by designing and performing a human subjects protocol under the supervision of a distinguished senior investigator mentor and a team of content expert educators. This is complemented by a tutorial focused on important translational skills. Results Since 2006, 40 Clinical Scholars have graduated from the programs and gone on to careers in academia (72%), government service (5%), industry (15%), and private medical practice (3%); 2 (5%) remain in training programs; 39/40 remain in translational research careers with 23 National Institute of Health awards totaling $23 million, foundation and philanthropic support of $20.3 million, and foreign government and foundation support of $6 million. They have made wide ranging scientific discoveries and have endeavored to translate those discoveries into improved human health. Conclusion The Rockefeller Clinical Scholars (KL2) program provides one model for translational science training.
first_indexed 2024-04-10T04:58:03Z
format Article
id doaj.art-677a2c7991f24b4ca0836dd7348348af
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:58:03Z
publishDate 2017-10-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-677a2c7991f24b4ca0836dd7348348af2023-03-09T12:29:34ZengCambridge University PressJournal of Clinical and Translational Science2059-86612017-10-01128529110.1017/cts.2017.308The Rockefeller University Clinical Scholars (KL2) program 2006–2016Sarah J. Schlesinger0Michelle Romanick1Jonathan N. Tobin2Donna Brassil3Rhonda G. Kost4Rita Devine5Barbara O’Sullivan6Roger D. Vaughan7Yupu Liang8Joel Correa da Rosa9Maija Williams10James G. Krueger11Barry S. Coller12Center for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USA Clinical Directors Network, Inc., New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USA Department of Biostatistics, Columbia University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USA Introduction and Methods The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program. The program consists of ∼15 trainees supported by the Clinical and Translational Science Award KL2 award and University funds. It is designed to provide an optimal environment for junior translational investigators to develop team science and leadership skills by designing and performing a human subjects protocol under the supervision of a distinguished senior investigator mentor and a team of content expert educators. This is complemented by a tutorial focused on important translational skills. Results Since 2006, 40 Clinical Scholars have graduated from the programs and gone on to careers in academia (72%), government service (5%), industry (15%), and private medical practice (3%); 2 (5%) remain in training programs; 39/40 remain in translational research careers with 23 National Institute of Health awards totaling $23 million, foundation and philanthropic support of $20.3 million, and foreign government and foundation support of $6 million. They have made wide ranging scientific discoveries and have endeavored to translate those discoveries into improved human health. Conclusion The Rockefeller Clinical Scholars (KL2) program provides one model for translational science training. https://www.cambridge.org/core/product/identifier/S2059866117003089/type/journal_articleTranslational researchTrainingKL2master’s degree
spellingShingle Sarah J. Schlesinger
Michelle Romanick
Jonathan N. Tobin
Donna Brassil
Rhonda G. Kost
Rita Devine
Barbara O’Sullivan
Roger D. Vaughan
Yupu Liang
Joel Correa da Rosa
Maija Williams
James G. Krueger
Barry S. Coller
The Rockefeller University Clinical Scholars (KL2) program 2006–2016
Journal of Clinical and Translational Science
Translational research
Training
KL2
master’s degree
title The Rockefeller University Clinical Scholars (KL2) program 2006–2016
title_full The Rockefeller University Clinical Scholars (KL2) program 2006–2016
title_fullStr The Rockefeller University Clinical Scholars (KL2) program 2006–2016
title_full_unstemmed The Rockefeller University Clinical Scholars (KL2) program 2006–2016
title_short The Rockefeller University Clinical Scholars (KL2) program 2006–2016
title_sort rockefeller university clinical scholars kl2 program 2006 2016
topic Translational research
Training
KL2
master’s degree
url https://www.cambridge.org/core/product/identifier/S2059866117003089/type/journal_article
work_keys_str_mv AT sarahjschlesinger therockefelleruniversityclinicalscholarskl2program20062016
AT michelleromanick therockefelleruniversityclinicalscholarskl2program20062016
AT jonathanntobin therockefelleruniversityclinicalscholarskl2program20062016
AT donnabrassil therockefelleruniversityclinicalscholarskl2program20062016
AT rhondagkost therockefelleruniversityclinicalscholarskl2program20062016
AT ritadevine therockefelleruniversityclinicalscholarskl2program20062016
AT barbaraosullivan therockefelleruniversityclinicalscholarskl2program20062016
AT rogerdvaughan therockefelleruniversityclinicalscholarskl2program20062016
AT yupuliang therockefelleruniversityclinicalscholarskl2program20062016
AT joelcorreadarosa therockefelleruniversityclinicalscholarskl2program20062016
AT maijawilliams therockefelleruniversityclinicalscholarskl2program20062016
AT jamesgkrueger therockefelleruniversityclinicalscholarskl2program20062016
AT barryscoller therockefelleruniversityclinicalscholarskl2program20062016
AT sarahjschlesinger rockefelleruniversityclinicalscholarskl2program20062016
AT michelleromanick rockefelleruniversityclinicalscholarskl2program20062016
AT jonathanntobin rockefelleruniversityclinicalscholarskl2program20062016
AT donnabrassil rockefelleruniversityclinicalscholarskl2program20062016
AT rhondagkost rockefelleruniversityclinicalscholarskl2program20062016
AT ritadevine rockefelleruniversityclinicalscholarskl2program20062016
AT barbaraosullivan rockefelleruniversityclinicalscholarskl2program20062016
AT rogerdvaughan rockefelleruniversityclinicalscholarskl2program20062016
AT yupuliang rockefelleruniversityclinicalscholarskl2program20062016
AT joelcorreadarosa rockefelleruniversityclinicalscholarskl2program20062016
AT maijawilliams rockefelleruniversityclinicalscholarskl2program20062016
AT jamesgkrueger rockefelleruniversityclinicalscholarskl2program20062016
AT barryscoller rockefelleruniversityclinicalscholarskl2program20062016